APA (7th ed.) Citation

Wang, L., Lei, X., & Wang, X. (2022). Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study. Computational & Mathematical Methods in Medicine, 1. https://doi.org/10.1155/2022/2848220

Chicago Style (17th ed.) Citation

Wang, Lihua, Xiaoxia Lei, and Xin Wang. "Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study." Computational & Mathematical Methods in Medicine 2022: 1. https://doi.org/10.1155/2022/2848220.

MLA (9th ed.) Citation

Wang, Lihua, et al. "Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study." Computational & Mathematical Methods in Medicine, 2022, p. 1, https://doi.org/10.1155/2022/2848220.